| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |